Component

Gut microbial composition in high-fat-diet-fed mice

Experimental species, exposure and limitations are retained on each linked claim.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. Oral indicaxanthin altered gut microbial relative abundances in high-fat-diet-fed male mice.

    Experimental context and source evidence
    dose
    High-fat diet for 10 weeks then indicaxanthin for 4 weeks; abstract reports 0.86 mg/kg/day, methods state 0.4 mg/kg twice daily
    duration
    4 treatment weeks; eight mice/group
    evidence_access
    Primary open full text, relevant results/methods and PubMed metadata.
    evidence_scope
    literature_reviewed; model-specific source-derived curation
    experimental_model
    Male mice with diet-induced obesity
    limitations
    Dose wording differs between abstract and methods and is preserved unresolved. Changes in microbial abundance do not demonstrate measured SCFA production or microbiota-mediated causation of brain changes. Article assigned 2026 issue; earlier online indexing retained in PubMed.
    nutrient_topic
    Dedicated indicaxanthin chapter; original betalain family identity and shared claims preserved. · Indicaxanthin
    organism
    Male mice with diet-induced obesity
    plain_language
    Oral indicaxanthin altered gut microbial relative abundances in high-fat-diet-fed male mice.
    primary_references
    Positive impact of indicaxanthin from Opuntia ficus-indica fruit on high-fat diet-induced neuronal damage and gut microbiota dysbiosis. (2026). https://pubmed.ncbi.nlm.nih.gov/39314163/ DOI: 10.4103/NRR.NRR-D-23-02039
    route
    Oral indicaxanthin in water
    tissue
    Cerebral cortex and gut microbiota

    Indicaxanthin: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 481–490

    Original AI-assisted curation of thirteen additional primary studies, with twenty-six existing claims from eight studies linked unchanged. Study-specific citations and limitations retained. Not publisher full text. · supports · Male mice with diet-induced obesity · source_derived_draft · unverified_draft

    ## indicaxanthin-hfd-microbiota Oral indicaxanthin altered gut microbial relative abundances in high-fat-diet-fed male mice. Model/species: Male mice with diet-induced obesity Tissue: Cerebral cortex and gut microbiota Exposure: High-fat diet for 10 weeks then indicaxanthin for 4 weeks; abstract reports 0.86 mg/kg/day, methods state 0.4 mg/kg twice daily Route: Oral indicaxanthin in water Duration: 4 treatment weeks; eight mice/group Limits: Dose wording differs between abstract and methods and is preserved unresolved. Changes in microbial abundance do not demonstrate measured SCFA production or microbiota-mediated causation of brain changes. Article assigned 2026 issue; earlier online indexing retained in PubMed. Primary reference: Positive impact of indicaxanthin from Opuntia ficus-indica fruit on high-fat diet-induced neuronal damage and gut microbiota dysbiosis. (2026). https://pubmed.ncbi.nlm.nih.gov/39314163/ DOI: 10.4103/NRR.NRR-D-23-02039 Access: Primary open full text, relevant results/methods and PubMed metadata.
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards